TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32282539

Group type: EXPERIMENTAL
Intervention: Postoperative endoscopy to assess recurrence within 12 months
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endoscopic assessment in routine follow-up after first negative colonoscopy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Postoperative immunoprophylaxis in naïve patients with known risk factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prescribing biologics over immunosuppressants based on risk factors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immediate prophylaxis for fistulizing phenotype, perianal disease, or concomitant colonic involvement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endoscopy-driven treatment in long-standing disease after failure of thiopurines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Endoscopy-driven treatment in elderly patients
Number of subjects: 0
Study: 32054425

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) with decalcified freeze-dried bone allograft (DFDBA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) alone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open flap debridement (OFD) alone
Number of subjects: 60
Study: 35075174

Group type: EXPERIMENTAL
Intervention: Facial sheet masks applied for 5, 10, 15, 20, 25, and 30 minutes
Number of subjects: 175

Group type: COMPARATOR
Intervention: Four types of facial sheet masks applied for 15 minutes
Number of subjects: 175
Study: 34375749

Group type: EXPERIMENTAL
Intervention: Prompt to perform stress management exercise via apps
Number of subjects: 75

Group type: COMPARATOR
Intervention: No prompt
Number of subjects: 75
Study: 32644170

Group type: EXPERIMENTAL
Intervention: EvoTears (semi-fluorinated alkane eye drops), prescribed four times a day for 5 weeks
Number of subjects: 40
Study: 35273223

Group type: EXPERIMENTAL
Intervention: Newly designed patch fabricated by blending poly(L-lactic acid) and poly(ε-caprolactone) exposed to amniotic fluid for 16 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Newly designed patch fabricated by blending poly(L-lactic acid) and poly(ε-caprolactone) exposed to phosphate-buffered saline (PBS) for 16 weeks
Number of subjects: 0
Study: 34535165

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) at a dose of 400 mg/daily for 8 weeks
Number of subjects: 0
Study: 32564128

Group type: EXPERIMENTAL
Intervention: Cisplatin plus gemcitabine (GP arm)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Carboplatin plus gemcitabine (GC arm)
Number of subjects: 102
Study: 34233357

Group type: EXPERIMENTAL
Intervention: Ozonated water
Number of subjects: 16

Group type: COMPARATOR
Intervention: Antimicrobial soap and water
Number of subjects: 16
Study: 33079705

Group type: EXPERIMENTAL
Intervention: Urtica urens mother tincture (UUMT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Individualized homeopathy (IH)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Individualized homeopathy (IH) + Urtica urens mother tincture (UUMT)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 90
Study: 33394581

Group type: EXPERIMENTAL
Intervention: FEAR index in dysplastic hips (mean 5° ± 10°)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: FEAR index in borderline dysplastic hips
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: FEAR index cutoff of -1.3°
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: ROC-AUC for FEAR index
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: FEAR index in older dysplastic hips
Number of subjects: 206

Group type: COMPARATOR
Intervention: FEAR index in control hips
Number of subjects: 206
Study: 32465450

Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3) LVAD implantation
Number of subjects: 125
Study: 35218601

Group type: EXPERIMENTAL
Intervention: Patient-centered consent process designed through collaboration with a patient advisory panel and a central institutional review board (CIRB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Remote consent process
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adaptive randomization
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Information sheet developed for patients and surrogates after enrollment
Number of subjects: 0
Study: 32109255

Group type: EXPERIMENTAL
Intervention: Hybrid Assistive Limb (HAL) training (4 days/week for 4 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional gait training only
Number of subjects: 32
Study: 34772904

Group type: EXPERIMENTAL
Intervention: Slackline training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control condition (ergometer-based aerobic exercise)
Number of subjects: 28
Study: 33823379

Group type: EXPERIMENTAL
Intervention: Scenario simulation-based education intervention and fever education booklet
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group received only the fever education booklet
Number of subjects: 160
Study: 36182773

Group type: EXPERIMENTAL
Intervention: MRUP at 10 min after methadone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Methadone alone without MRUP
Number of subjects: 100
Study: 36214097

Group type: EXPERIMENTAL
Intervention: Worry (T1)
Number of subjects: 650

Group type: EXPERIMENTAL
Intervention: Rumination (T1)
Number of subjects: 650
Study: 34656192

Group type: EXPERIMENTAL
Intervention: Transdiagnostic CBT
Number of subjects: 179

Group type: COMPARATOR
Intervention: Single-diagnosis CBT
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 179
Study: 33208014

Group type: EXPERIMENTAL
Intervention: External diaphragmatic pacing (EDP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Anti‐CCP therapy (negative control group)
Number of subjects: 50
Study: 33307236

Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation with PIPS technique
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Er:YAG laser irradiation with SWEEPS technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no irradiation)
Number of subjects: 60
Study: 36281151

Group type: EXPERIMENTAL
Intervention: TXA + DEXA (15 mg/kg TXA before skin incision and 3 hours later; 20 mg dexamethasone intravenously after the onset of anesthesia, and again 24 hours later)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: TXA + DEXA
Number of subjects: 100

Group type: COMPARATOR
Intervention: TXA (placebo group)
Number of subjects: 100
Study: 33402599

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiotherapy (nCRT)
Number of subjects: 117
Study: 35842755

Group type: EXPERIMENTAL
Intervention: Caloric Restriction (CR)
Number of subjects: 188

Group type: COMPARATOR
Intervention: Control (ad lib diet)
Number of subjects: 188
Study: 34237755

Group type: EXPERIMENTAL
Intervention: Midurethral sling
Number of subjects: 403

Group type: COMPARATOR
Intervention: Midurethral sling alone
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Behavioral and pelvic floor muscle therapy combined with midurethral sling
Number of subjects: 403
Study: 32823599

Group type: EXPERIMENTAL
Intervention: Sedentary behaviour fragmentation (SBF)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Continuous LIPA
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control
Number of subjects: 35
Study: 35026462

Group type: EXPERIMENTAL
Intervention: Sigmoidectomy with primary anastomosis (PA)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Hartmann's Procedure (HP)
Number of subjects: 119
Study: 33059580

Group type: COMPARATOR
Intervention: Diet-exercise
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 604

Group type: EXPERIMENTAL
Intervention: Pitavastatin
Number of subjects: 604
Study: 32650074

Group type: EXPERIMENTAL
Intervention: Topical benzoyl peroxide
Number of subjects: 4348

Group type: EXPERIMENTAL
Intervention: Hydrogen peroxide
Number of subjects: 4348
Study: 34786990

Group type: EXPERIMENTAL
Intervention: Foot-core training program (8 weeks, 3 times/week)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Higher training volume
Number of subjects: 118
Study: 33377533

Group type: EXPERIMENTAL
Intervention: Sealants applied to primary molars
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (unsealed primary molars)
Number of subjects: 90
Study: 33322063

Group type: EXPERIMENTAL
Intervention: DKB114
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 36445625

Group type: EXPERIMENTAL
Intervention: Remote Ischaemic Conditioning (RIC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 80
Study: 34058011

Group type: EXPERIMENTAL
Intervention: Whole-head parallel design
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Split-head paired design
Number of subjects: 155
Study: 33712965

Group type: EXPERIMENTAL
Intervention: Ilizarov ligamentotaxis
Number of subjects: 72

Group type: COMPARATOR
Intervention: Locked volar plating
Number of subjects: 72
Study: 33832957

Group type: EXPERIMENTAL
Intervention: Mulberry twig alkaloids (SZ‐A)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Acarbose
Number of subjects: 600
Study: 35028615

Group type: EXPERIMENTAL
Intervention: PXL770 500 mg QD
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 33236706

Group type: EXPERIMENTAL
Intervention: Combination treatment with dual antiparasitic therapy and corticosteroids
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cysticidal therapy
Number of subjects: 0
Study: 35594928

Group type: EXPERIMENTAL
Intervention: Icon-only labels
Number of subjects: 1327

Group type: EXPERIMENTAL
Intervention: Icon-plus-text labels
Number of subjects: 1327

Group type: COMPARATOR
Intervention: Control label
Number of subjects: 1327

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1327
Study: 34061558

Group type: COMPARATOR
Intervention: Nivolumab plus ipilimumab, pembrolizumab plus axitinib, nivolumab plus cabozantinib, pembrolizumab plus lenvatinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atezolizumab and pembrolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Enfortumab vedotin
Number of subjects: 0
Study: 32877425

Group type: EXPERIMENTAL
Intervention: eQuoo app (gamified mobile mental health intervention)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Cognitive behavioral therapy journal app (active control)
Number of subjects: 358

Group type: COMPARATOR
Intervention: No-intervention waitlist (inactive control)
Number of subjects: 358
Study: 34634832

Group type: EXPERIMENTAL
Intervention: Handwashing (HW) for 30 seconds
Number of subjects: 14

Group type: COMPARATOR
Intervention: Alcohol-based sanitization for 30 seconds
Number of subjects: 14
Study: 34703485

Group type: EXPERIMENTAL
Intervention: Aromatherapy with lavender
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Aromatherapy with damask rose
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control group (routine nursing care)
Number of subjects: 97
Study: 35387431

Group type: EXPERIMENTAL
Intervention: Energy Drink (3 mg caffeine per kg of body weight)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo (similar amount of sugar without conventional ED ingredients)
Number of subjects: 27
Study: 34602550

Group type: EXPERIMENTAL
Intervention: Palonosetron (PALO)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Granisetron (GRA)
Number of subjects: 267
Study: 36231330

Group type: EXPERIMENTAL
Intervention: COLD
Number of subjects: 12

Group type: COMPARATOR
Intervention: RT
Number of subjects: 12
Study: 33892764

Group type: EXPERIMENTAL
Intervention: Constraint-induced Aphasia Therapy Plus (CIAT Plus)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Multi-modality Aphasia Therapy (M-MAT)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: CIAT Plus
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: M-MAT
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: CIAT Plus vs M-MAT
Number of subjects: 216
Study: 32569239

Group type: EXPERIMENTAL
Intervention: Half dose of low‐molecular‐weight heparin sodium injection (FLUXUM)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Full dose of low‐molecular‐weight heparin sodium injection (FLUXUM)
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Argatroban injection
Number of subjects: 307

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 307
Study: 34284646

Group type: EXPERIMENTAL
Intervention: Dry needling (DN) into the nodule of the MTrP
Number of subjects: 46

Group type: COMPARATOR
Intervention: Dry needling (DN) into the taut band (TB) of the MTrP
Number of subjects: 46
Study: 34316024

Group type: EXPERIMENTAL
Intervention: Tasimelteon
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 35807800

Group type: EXPERIMENTAL
Intervention: Yerba Mate (YM) supplementation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 34469262

Group type: EXPERIMENTAL
Intervention: Brief Interactive Training Sessions (BITS)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Wait-list (Control)
Number of subjects: 52
Study: 34904183

Group type: EXPERIMENTAL
Intervention: AR-navigated microscope
Number of subjects: 55

Group type: COMPARATOR
Intervention: Conventional neuronavigation
Number of subjects: 55
Study: 34387274

Group type: EXPERIMENTAL
Intervention: Steady-state responses of cortico-cortical evoked potentials (SSCCEPs)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Conventional cortico-cortical evoked potentials (CCEPs)
Number of subjects: 11
Study: 34939824

Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Blood Glucose Meter (BGM)
Number of subjects: 42
Study: 34851729

Group type: EXPERIMENTAL
Intervention: 75 μg fentanyl
Number of subjects: 23
Study: 32544459

Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0
Study: 35644684

Group type: EXPERIMENTAL
Intervention: Low-iodine intake diet
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Egg added to diet
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: 125mL milk added to diet
Number of subjects: 37

Group type: COMPARATOR
Intervention: Comparison of iodine intake and excretion increments
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Overall iodine requirement evaluation
Number of subjects: 37
Study: 33617161

Group type: EXPERIMENTAL
Intervention: Isoelastic monoblock cup (RM Pressfit vitamys; Mathys)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Modular titanium cup (Allofit-S IT Alloclassic with a polyethylene liner; Zimmer)
Number of subjects: 50
Study: 616766373

Group type: EXPERIMENTAL
Intervention: Premedication (Group B)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Premedication and standardised preoperative information (Group C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard pain management (Group A)
Number of subjects: 60
Study: 35133631

Group type: EXPERIMENTAL
Intervention: Atorvastatin treatment
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 196
Study: 33506195

Group type: EXPERIMENTAL
Intervention: Oral sedation (lorazepam 1 mg/oxycodone 5 mg)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 33719899

Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 19
Study: 34874654

Group type: EXPERIMENTAL
Intervention: Cytoflavin tablets, 2 tablets 2 times a day for 25 days
Number of subjects: 100

Group type: COMPARATOR
Intervention: Other drugs (vitamins, nootropic drugs)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Cytoflavin
Number of subjects: 100
Study: 36374982

Group type: EXPERIMENTAL
Intervention: Cordyceps cicadae mycelium supplementation (1,050 mg daily for 90 days)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 32661006

Group type: EXPERIMENTAL
Intervention: Interferon β‐1a (IFN β‐1a) administered at a dose of 44-μg/ml (12 million IU/ml) subcutaneously injected three times weekly for two consecutive weeks, in addition to national protocol medications (hydroxychloroquine plus lopinavir-ritonavir or atazanavir-ritonavir)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group received only national protocol medications (hydroxychloroquine plus lopinavir-ritonavir or atazanavir-ritonavir)
Number of subjects: 92
Study: 33485340

Group type: EXPERIMENTAL
Intervention: PA enabling uniform (shorts, polo shirt, sports shoes)
Number of subjects: 2180

Group type: COMPARATOR
Intervention: Usual traditional uniform
Number of subjects: 2180
Study: 32390248

Group type: EXPERIMENTAL
Intervention: Tolperisone (150 mg TID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclobenzaprine (10 mg TID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35759108

Group type: EXPERIMENTAL
Intervention: Repetitive trans-spinal magnetic stimulation (rTSMS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 100
Study: 33078467

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT) - Group format
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT) - Individual format
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT) - Both formats (Group and Individual)
Number of subjects: 268
Study: 35694708

Group type: EXPERIMENTAL
Intervention: Self-made Hewei decoction plus conventional western medicine
Number of subjects: 166

Group type: COMPARATOR
Intervention: Conventional western medicine
Number of subjects: 166
Study: 34301974

Group type: EXPERIMENTAL
Intervention: 20 mg escitalopram for 7 days
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 60
Study: 32279888

Group type: EXPERIMENTAL
Intervention: Reso‐Pac® dressing
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (no dressing)
Number of subjects: 100
Study: 36349334

Group type: EXPERIMENTAL
Intervention: BASPLA
Number of subjects: 120

Group type: COMPARATOR
Intervention: CLA
Number of subjects: 120
Study: 33777423

Group type: EXPERIMENTAL
Intervention: Telenursing and telehealth awareness
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Positive attitude towards telenursing and telehealth
Number of subjects: 523

Group type: COMPARATOR
Intervention: Telehealth awareness by education level
Number of subjects: 523

Group type: COMPARATOR
Intervention: Positive attitude towards telehealth and telenursing by profession
Number of subjects: 523
Study: 34898083

Group type: EXPERIMENTAL
Intervention: One-glass test
Number of subjects: 360

Group type: COMPARATOR
Intervention: Four-glass test
Number of subjects: 360
Study: 35644305

Group type: EXPERIMENTAL
Intervention: GDC-4379 10 mg QD
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GDC-4379 30 mg QD
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GDC-4379 40 mg BID
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GDC-4379 80 mg QD
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GDC-4379
Number of subjects: 48
Study: 32250534

Group type: EXPERIMENTAL
Intervention: Liraglutide (0.6 to 1.8 mg over 24 weeks)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 34304419

Group type: EXPERIMENTAL
Intervention: MR and JVE‐L combined vaccination group (experimental group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MR single vaccination group (control group)
Number of subjects: 0
Study: 33040011

Group type: EXPERIMENTAL
Intervention: Internal Fixation (IF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Arthroplasty
Number of subjects: 0
Study: 36453305

Group type: EXPERIMENTAL
Intervention: Sibling Motivational Card (SMC)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Oral counseling
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 234
Study: 33765257

Group type: EXPERIMENTAL
Intervention: Pharmacist-directed home blood pressure monitoring (HBPM)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 126
Study: 32610487

Group type: EXPERIMENTAL
Intervention: High-intensity strategies
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Low-intensity strategies
Number of subjects: 69

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 69
Study: 34957621

Group type: EXPERIMENTAL
Intervention: Health Literacy Education (HL-AE)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Antenatal Education (AE)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 182
Study: 32651768

Group type: EXPERIMENTAL
Intervention: Racemic epinephrine (RE) nebulization, 0.2 ml of RE added to 1.8 ml of distilled water, re-administered if needed on 6 h.
Number of subjects: 80

Group type: COMPARATOR
Intervention: 3% hypertonic saline (HS) nebulization, 2 ml of 3% HS nebulized, frequency of 1 to 4 h.
Number of subjects: 80
Study: 35289756

Group type: EXPERIMENTAL
Intervention: Person-centered eHealth intervention (telephone support and web-based platform)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 209
Study: 35018614

Group type: EXPERIMENTAL
Intervention: Active group (participants moved a virtual paddle to bounce target objects)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Passive group (participants viewed recordings of trials from the active groups)
Number of subjects: 0
Study: 33199044

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted plasma phospholipid AA concentrations
Number of subjects: 367643
Study: 32336236

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 15245

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 15245
Study: 33662615

Group type: EXPERIMENTAL
Intervention: Subthreshold nanosecond laser (SNL) treatment
Number of subjects: 212

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 212

Group type: COMPARATOR
Intervention: Overall comparison of SNL vs sham
Number of subjects: 212
Study: 34670994

Group type: EXPERIMENTAL
Intervention: Weight and Pain Management Program (12 sessions, 90 minutes each, plus supervised exercise 3 times per week)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard care of RA
Number of subjects: 50